The 13th World Congress of Regenerative Medicine & Stem Cell (RMSC-2019)
★ Program Layout

The 13th World Congress of

 

Regenerative Medicine Stem Cell

Theme: Voice of Chinese Stem Cells

Time: November 1-3, 2019
Place: Dalian, China

  • Program Design
  • Plenary Hall Opening Ceremony
  • Chapter 1 Plenary Hall Nobel Laureate Forum
    -Current Trend, Frontiers and Wondrous Achievement in the Triad World of RMSC & Tissue Engineering
  • Chapter 2 New Leadership Stage Stem Cells & Genome Editing Forum
    -The Appearance of Hottest Discovery and Powerful Inventions in RMSC and Tissue Engineering
  • Chapter 3 Humanity Sacred Office Legal Dialogs & Panel Discussions
    -Global Actions on Unproven Trials and Practices, the Universal Law, Policy, Ethic and Social Issues on Stem
    Cells
  • Chapter 4 Master Rostrum World Academician Forum
    -Voice of Great Scientists and Masters on the Great Achievement and Next Big Things of Stem Cells, Tissue
    Engineering Toward Regenerative Medicine
  • Chapter 5 Friendship Floral World Global RMSC Network Partnership Forum
    -Opportunities and Pathways for Emerging Regenerative Medicine, Stem Cells and Tissue Engineering
    International Projects
  • Chapter 6 Glory Hall of Fame Life Spring Forum
    -Commemorating a Great Scientist’s Life Achievements on Embryonic Stem Cell Research
  • Special Activity Alpha-Zone TV Live
    -Media Program
    ● Impacting of Emerging Regulatory on Stem Cell Research
    ● What’s Next for Potential Cures of Major Diseases
    ● What we should differentiate the True Stem Cell Functions and Business Propaganda
  • Chapter 7 Stem Cell Biology and Interdisciplinary Research
    • Session 7-1: Advances in Stem Cell Biology
    • Session 7-2: Stem Cell CRISPR/Cas and Genome Editing
    • Session 7-3: Hematopoietic and Embryonic Stem Cells of Bio-Banking
    • Session 7-4: Stem Cell Epigenetics
    • Session 7-5: Stem Cell Fate- Self-renewal, Maintenance, Differentiation, Aging
    • Session 7-6: Stem Cells and Microenvironment
    • Session 7-7: Gene, Pluripotency, Differentiation and Reprogramming
    • Session 7-8: Stem Cell Transplantation
  • Chapter 8 Roadmap of Tissue Engineering
    • Session 8-1: Tissue Engineering Market Trend
    • Session 8-2: Biomaterials in Tissue Engineering
    • Session 8-3: New Scaffolds of Tissue Engineering and Highly Effective TE Modeling
    • Session 8-4：Scaffold-free Strategies in TE and RMSC
    • Session 8-5: Cell Source Selections for Tissue Engineering
    • Session 8-6: Signaling Molecules for Tissue Engineering
    • Session 8-7: RNAi Assisted Tissue Regeneration
  • Chapter 9 Blue Print of Regenerative Medicine
    • Session 9-1: Supporting Healing Therapies Technologies
    • Session 9-2: Regenerative Cell Therapy
    • Session 9-3: Restoration of Regenerative Potential
    • Session 9-4: Nondestructive Quality Control in Regenerative Medicine
    • Session 9-5: Bioreactor Technologies
    • Session 9-6: In vitro Fertilization
  • Chapter 10 Breakthroughs in Disclosing Specific Functional Stem Cells
    • Session 10-1: Stem Cell Modification and Functions
    • Session 10-2: Stem Cell Memory T cells (TSCM)
    • Session 10-3: Mechanisms of Stem-Cell Functions and Activation
    • Session 10-4: Stem Cell (ES)-Specific Enhancers Modulators, Regulators and Inhibitors
  • Chapter 11 Scientific Innovations in Tissue & Organ Engineering
    • Session 11-1: Robust Tissue Engineering Biology
    • Session 11-2: CRISPR human embryo，
    • Session 11-4: Transplantation and Regenerative Medicine
    • Session 11-5: Immunomodulation in TE
    • Session 11-6: Top Trends in Organ Tissue Engineering
    • Session 11-6A: Bone, Oral and Craniofacial Tissues Repair and regeneration
    • Session 11-6B: Skin, Cartilage, Tendon and Connective Tissue Regeneration
    • Session 11-6C: Hair and Hair Follicles Regeneration
    • Session 11-6D: Cardiac Tissue Engineering
    • Session 11-6E: Brain Tissue Engineering
    • Session 11-6F: Liver Tissue Engineering
    • Session 11-6G: Kidney and Bladder Tissue Engineering
    • Session 11-6H: Skin Tissue Engineering
    • Session 11-6I: Bone and Cartilage Tissue Engineering
    • Session 11-6J: Skeletal Muscle Tissue
    • Session 11-6K: Tendon Tissue Engineering
    • Session 11-6L: Corneal Tissue Engineering
    • Session 11-6M: Vascular Tissue Engineerings
  • Chapter 12 Current Milestones in RMSC
    • Session 12-1: Waking up Our Hearts
    • Session 12-2: New Blood
    • Session 12-3: Regenerative therapy in Aesthetic Plastic Surgery
    • Session 12-4: Regenerative Rehabilitation
    • Session 12-5: Regenerative Medicine and Immunotherapy
    • Session 12-6: Gene Delivery in Tissue Engineering
    • Session 12-7: Mechanobiology of Regenerative Medicine
  • Chapter 13 Disruptive Breakthroughs in Stem Cells
    • Session 13-1: New Disease Models for iPSC and MSCs
    • Session 13-2: Stem Cell Biomarkers and Diagnostic Platforms
    • Session 13-3: Stem Cell Nanotechnology
    • Session 13-4: Novel Bioanalytics for Stem-Cell Characteristics, Function and Applications
    • Session 13-5: Stem Cell Imaging
  • Chapter 14 Disruptive Tech in Tissue Engineering
    • Session 14-1: Tissues and Organs on Chip
    • Session 14-2: 3D/4D Bioprinting
    • Session 14-3: Cancer Microfabricated Tissue-Engineered Models
    • Session 14-4: Real-time Control and Remote Actuation of TE Systems or Constructs
    • Session 14-5: Microrobotics in Tissue Engineering
    • Session 14-6: QA/QC of Tissue Engineering
    • Session 14-7: Enabled Methods for Cell & Tissue Orientation
    • Session 14-8: Injectable Scaffolds
  • Chapter 15 Top 10 Innovative Regenerative Medicine
    • Session 15-1: Modeling and Monitoring of Regeneration Medicine
    • Session 15-2: Analysis Technologies and Computational Stem Cell Biology
    • Session 15-3: Diagnostic & Imaging Technologies
    • Session 15-4: CRISPR/Gene Editing
    • Session 15-5: Tissue & Organ Regeneration, Repair and Reconstruction
    • Session 15-6: Stem Cells in Aesthetic Plastic Surgery
    • Session 15-7: Convenient Stem cell Preservation Methods
    • Session 15-8: Methods of Collection, Processing and Testing
    • Session 15-9: Cryopreservation and Thawing
    • Session 15-10: Culturing in Bioreactors and Synthetic Media
  • Chapter 16 xLab Regenerative Drug Discovery
    • Session 16-1: Platform Technology for Stem-Cell Drug Discovery
    • Session 16-2: Targets and Regenerative Medicine Drug Discovery
    • Session 16-3: Gene and Cell Therapy
    • Session 16-4: Pharmacology
    • Session 16-5: Advances in Stem Cell Encapsulation
    • Session 16-6: Polymer, Biopolymer, and Matrix Mediated Delivery of Cell Signaling Proteins
    • Session 16-7：Clinical Trials of RMSC
    • Session 16-8: Stem Cell Therapy Development and Regulation as Veterinary Medicine
  • Chapter 17 Toolbox RMSC Medical Device
    • Session 17-1: Laser Perforation Devices in TE and RMSC
    • Session 17-2: Regenerative Medical Devices for Endocrine/Metabolic Diseases
    • Session 17-3: Medical Device and Tissue Engineering
    • Session 17-4: Smart Sensors and Devices for Regenerative Medicine
    • Session 17-5: Emerging Medical Devices for Stem Cell Therapy
  • Chapter 18 Smart World AI & Smart Materials in RMSC
    • Session 18-1: Novel Smart Materials for RMSC and Tissue Engineering
    • Session 18-2: AI-Guided Regenerative Medicine
    • Session 18-3: Machine Learning in Stem Cell R & D
    • Session 18-4: Electro Active Biomaterials and Electro Stimulation
    • Session 18-5: Clay Materials Regenerative Medicine
    • Session 18-6: Silk Biomaterials in TE
    • Session 18-7: Big-Data-Driven Stem Cell Science and Regenerative Medicine
    • Session 18-8: Nanotechnology for Tissue Engineering and Regenerative Medicine
  • Chapter 19 Upstream/Downstream Stem Cell Bioprocessing
    • Session 19-1 Cell Preservation, Distribution, and Handling
    • Session 19-2 Robust Stem Cell Culture and Differentiation
    • Session 19-3 Cell Bioprocessing Optimization
    • Session 19-4 Stem Cell Bioreactor Systems and Automation
    • Session 19-5 Process Monitoring and Quality Control
  • Chapter 20 Manufacturing Technologies in Stem Cells
    • Session 20-1: Highly Efficient Cell Therapy Isolation and Purification Technologies
    • Session 20-2: Biomanufacturing of iPSCs
    • Session 20-3: Bioprocessing of Mesenchymal Stem Cells and Their Derivatives
    • Session 20-4: Standardization and Regulatory Support
    • Session 20-5: Innovative QA/QC Technologies for Stem Cell Bioprocessing
  • Chapter 21 Approaches in Tissue Engineering
    • Session 21-1: Bionics Tissue Engineering
    • Session 20-2: Bioprinting and Live-cell Bioprinting
    • Session 21-3: Therapeutic Cloning
    • Session 21-4: Nerve Development in the Artificial Organ
    • Session 21-5: Vascularization Engineering
  • Chapter 22 Innovations in Regenerative Medicine Fabrication
    • Session 22-1: Design and Fabrication of Regenerative Cell Scalfold
    • Session 22-2: Regenerative Biomaterials and Additive Manufacturing
    • Session 22-3: Fabrication of Platelet-rich Plasma
    • Session 22-4: Improved Biomaterial Scaffold Fabrication Techniques
    • Session 22-5: Bioartificial Organs Fabrication
  • Chapter 23 Precision Medicine and Gene Detection
  • Chapter 24 CAR-T Therapy
  • Chapter 25 The Ten Transferences of RMSC-Vision, Compassion, Giving and Rewarding
    • Session 25-1：New Bio-Idea Proposals
    • Session 25-2：Business Plan Roads
    • Session 25-3：When Entrepreneurs Meet with VCs
    • Session 25-4：CEO Roundtable Conference
    • Session 25-5：Industry Park Forum
    • Session 25-6：Talent Exchange Forum
    • Session 25-7：Matchmaking and Partnering
    • Session 25-8：Meet with Mentors and Future Boss
    • Session 25-9：How to Write and Publish a High-Quality Paper
    • Session 25-10：1 to 1/ Face to Face Meetings
  • Chapter 26 Top 10 Cases in Human Stem Cell Medicine
    • Session 26-1: Stem Cell Therapy on Missing Teeth
    • Session 26-2: Stem Cells for Wound Healing
    • Session 26-3: Stem Cell Therapy on Spinal Cord Injury
    • Session 26-4: Baldness Stem Cell Therapy
    • Session 26-5: Blindness Stem Cell Therapy
    • Session 26-6: Stem Cells for Amyotrophic Lateral Sclerosis and Muscular Dystrophy
    • Session 26-7: Stem Cell Based Gene Therapy
    • Session 26-8: Stem Cell Therapy for Osteoarthritis and Rheumatoid Arthritis
    • Session 26-9: Stem Cell Therapy of Crohn's Disease
    • Session 26-10: Cancers’ Stem Cell Therapy
  • Chapter 27 Update on Current Human Tissue Engineering
    • Session 27-1: Cornea
    • Session 27-2: Vascular Tissue Engineering
    • Session 27-3: Extracellular Vesicles
    • Session 27-4: Dental Pulp Regeneration
    • Session 27-5: Neural Tissue
    • Session 27-6: Skeletal Muscle Tissue
    • Session 27-7: Myocardial Tissue
    • Session 27-8: Craniofacial Tissues
    • Session 27-9: Bone & Cartilage
    • Session 27-10: Abdominal Organs
    • Session 27-11: Anterior Cruciate Ligament
    • Session 27-12: Peripheral Nerve Engineering
    • Session 27-13: Platelet and Platelet Derived Biomaterials
    • Session 27-14: Gene2 Skin
    • Session 27-15: Human Vocal Fold
  • Chapter 28 Top Trend of Regenerative Medicine
    • Session 28-1: Cardiovascular Regenerative Therapy
    • Session 28-2: Personalized/ Precision Regenerative Medicine Approaches
    • Session 28-3: Regenerative Medicine for GI and HPB
    • Session 28-4: Novel Nerve Conduits
    • Session 28-5: Elastin in Regenerative Medicine
    • Session 28-6: Tissue Discovery and Blood Proteins for Regeneration
    • Session 28-7: Kidney and Endocrine Organs
    • Session 28-8: Novel Bone Engineering
    • Session 28-9: Animal Models for RMSC
    • Session 28-10: Clinical Management of ES and iPS Cells
    • Session 28-11: Regenerative Microenvironment Therapies
    • Session 28-12: Cell Therapies for Tendon Repair
    • Session 28-13: Burns and Wounds Healing
    • Session 28-14: Heart, Blood Vessel & Lung
    • Session 28-15: Ischemia Organs
  • Chapter 29 Global Stem Cell Translational Medicine
    • Session 29-1: Stem Cell Therapy on Heart Disorders
    • Session 29-2: Stem-Cell Therapy of Diabetes
    • Session 29-3: Stem Cell Therapy for Eye, Ear and Nose, Tongue Diseases
    • Session 29-4: RMSC for Brain and CNS Diseases
    • Session 29-5: RMSC for Liver, Kidney Disorders and Urogenital System
    • Session 29-6: Cancer Stem-Cell Therapy
    • Session 29-7: Stem-Cell Therapy for Muscle Disorders and Degrowing
    • Session 29-8: Stem Cell Treatment for Bones, Cartilage and Tendons Abnormalities
    • Session 29-9: Stem Cells for Skin Diseases
    • Session 29-10: Stem-Cell Therapy for Blood and Genetic Diseases
  • Chapter 30 Endless World of Stem Cells
    • Session 30-1 Immortality of Stem Cells
    • Session 30-2 Novel Hematopoietic Pluripotent Stem Cells
    • Session 30-3 Potentials of iPS Cells
    • Session 30-4 Human Germline Stem Cell
    • Session 30-5 Adult Endothelial Stem Cells
    • Session 30-6 Unlimited Potential of Stem Cells
    • Session 30-7 Spermatogonial Stem Cells
    • Session 30-8 Endless Supply of Artificial Blood
    • Session 30-9 Cancer Stem Cells
    • Session 30-10 Stem Cell Transplantation
    • Session 30-11 Mesenchymal Stem Cells
    • Session 30-12 Neural Stem Cells
    • Session 30-13 Muscle Stem Cells
    • Session 30-14 Stem Cell Fate and Activities
    • Session 30-15 Tissue-specific Stem Cells -“Adult” or “Somatic” Stem Cells
    • Session 30-16 Stem-Cell Derived Beta Cells
    • Session 30-17 Multipotent Stem Cells
    • Session 30-18 Totipotent Stem Cells/li>
    • Session 30-19 Hepatic Stellate Cells/transplantation
    • Session 30-20 You Can Propose Your Own Sessions Here
  • Chapter 31 A Stem Cell’s Fate
    • Session 31-1: The Coming Stem-Cell Revolution, and Life Span Extension
    • Session 31-2: Stem Cell Survival in Tissue Regeneration
    • Session 31-3: Shelf Life of Different Stem Cells
    • Session 31-4: Future of Autologous Stem Cell
    • Session 31-5: Contemporary Cryotechnologiesfor Long Term Stem-Cell, Tissue Storage
  • Chapter 32 Top Hospital Clinical Research Capacity Briefing
    • Session 32-1: Voice EU Top 10 Stem Cell Centers
    • Session 32-2: Voice of North America RMSC Hospitals
    • Session 32-3: Strength and Progress from Top Asia Hospitals
    • Session 32-4: Voice of Oceania Hospitals
    • Session 32-5: Voice of Africa Hospitals in RMSC Research
  • Chapter 33 Community Voice of Stem Cells and Regenerative Medicine
    • Session 33-1: PPP Models in Tissue Engineering and RMSC
    • Session 33-2: Global Stem Cell & RM Project Initiatives Briefing
    • Session 33-3: BIG Pharma ESG Strategy in RMSC
    • Session 33-4: Outlook of International RMSC Standard and Regulatory Landscape
    • Session 33-5: Open Source Research on Stem Cells
  • Chapter 34 Anti-aging RMSC-Are RMSC Panaceas or Forever Young Possible
    • Session 34-1: Mechanisms of Anti-aging Stem Cells
    • Session 34-2: Anti-aging Stem-Cell Discovery
    • Session 34-3: Rejuvenation of Aging Stem/Progenitor Cells
    • Session 34-4: Cosmetic Stem Cells and Aesthetic Medicine
    • Session 34-5: Anti-Aging Stem Cell Treatment
  • Chapter 35 Plant and Animal Stem Cells-Next Big Things in Stem Cell Cosmetic Industry
    • Session 35-1: Plant Stem Cell Biology
    • Session 35-2: Anti-Aging Plant Stem Cell Extracts
    • Session 35-3: Innovative Plant Stem Cell Technology
    • Session 35-4: Animal Stem Cell Therapy
    • Session 35-5: Animal Stem Cells and Animal Cloning
  • Chapter 36 Stem Cells Ethic Debate-What should be right Universal Moral Conducts
    • Session 36-1: Ethic Issues of Clinical Trials on Stem-Cell Drug Candidates -How to Evaluate Unseen Risks Volunteer Subjects
    • Session 36-2: Global Actions against Dubious Stem Cell Clinics
    • Session 36-3: Case Learning on Patients Sues
    • Session 36-4: Direct-To-Consumer Stem Cell Clinic Leaks
    • Session 36-5: Controversy Issues on Anti-aging Stem Cells Efforts
    • Session 36-6: Ethics on Unproven Stem-Cell Based Aesthetic Plastic Surgery
    • Session 36-7: Challenges and Non-Ethic Perspectives on Human-animal Hybrids
    • Session 36-8: The Ethical Issues Stem Cell Therapy
    • Session 36-9: Religion，Policy, Law and the Public Ethics of Stem-cell Research
    • Session 36-10: Stem Cell Biobanking – Ethics, Control Standards and Justice
  • Chapter 37 Challenges and Solutions to RMSC
    • Session 37-1: Issues Concerning in RMSC of Neural Disorders
    • Session 37-2: Safety Issues of Stem Cell-Based Therapy
    • Session 37-3: Stem Cellular Logistics and Supply Limits
    • Session 37-4: Barriers and Hackles Cross Board Regulation
    • Session 37-5: Issues in regarding Insurance and Medical Reimbursement
  • Chapter 38 Sino-X RMSC Partnership Forum
    • Session 38-1: Euro-Asia RMSC Partnership Forum
    • Session 38-2: Sino-German RMSC Partnership Forum
    • Session 38-3: Sino-Switzerland RMSC Partnership Forum
    • Session 38-4: Sino-US RMSC Partnership Forum
    • Session 38-5: Sino-Canada RMSC Partnership Forum
    • Session 38-6: Sino-French RMSC Partnership Forum
    • Session 38-7: Sino-Italy RMSC Partnership Forum
    • Session 38-8: Sino-Russian RMSC Partnership Forum
    • Session 38-9: Sino-Israel RMSC Partnership Forum
    • Session 38-10: Sino-Australia/New Zealand RMSC Partnership Forum
    • Session 38-11: R & B RMSC Partnership Forum
    • Session 38-12: Sino-Singapore, Malaysia and Thail and RMSC Partnership Forum
    • Session 38-13: Sino-Spain RMSC Partnership Forum
    • Session 38-14: Sino-Japan-Korea RMSC Partnership Forum
    • Session 38-15: Sino-Africa RMSC Partnership Forum
    • Session 38-16: Cross-Trait RMSC Regional Partnership Forum-Integrative R & D between Mainland China & Taiwan
    • Session 38-17: GHM Big Bay RMSC Partnership Forum-Strategic Alliance among Guangdong, Hong Kong and Macao
  • Chapter 39 Voice of Chinese Stem Cells and Regenerative Medicine
    • Session 39-1: Neural Stem Cell Therapy Cerebral Palsy
    • Session 39-2: MSCs Treatment on Systemic Lupus Nephritis
    • Session 39-3: MSCs for Decompensation of HB cirrhosis
    • Session 39-4: Neuropathic Pain
    • Session 39-5: Psoriasis
    • Session 39-6: Rheumatic Immune Disease
    • Session 39-7: Pediatri Hematological Neoplasms
    • Session 39-8: Genetic Diseases
    • Session 39-9: Immuno Diseases
    • Session 39-10: Acute Myocardial Infarction
    • Session 39-11: Premature Ovarian Failure
    • Session 39-12: Interstitial Lung Disease
    • Session 39-13: Knee Osteoarthritis
    • Session 39-14: Parkinson's Disease
    • Session 39-15: Retinitis Pigmentosa
    • Session 39-16: Retinitis Pigmentosa
    • Session 39-17: Age-Related Macular Degeneration
    • Session 39-18: Ulcerative Colitis
    • Session 39-19: Bone Repair
    • Session 39-20: Empty Nose Syndrome
    • Session 39-21: Infertility
    • Session 39-22: Optic Neuromyelitis
    • Session 39-23: Thin Endometrium
    • Session 39-24: Pulmonary Hypertension Caused By Copd
    • Session 39-25: Meniscus Injury
    • Special Topic Roundtables
    • Roundtable 1 What’s Wrong with CRISPR Babies
    • Roundtable 2 Recent Developments and Factors Affecting Stem Cell Research
    • Roundtable 3 Privacy, Ethic Society Legal Issues on Hematopoietic and Embryonic Stem Cells and Bio-Banking
    • Roundtable 4 Responsible Innovation and Trials with Autologous Stem Cells
    • Roundtable 5 Best Practice on RMSC Translational Medicine
    Chapter 40 Training Courses: Stem Cell Clinical Research Technology and Policy Training
    • Roundtable 1 What’s Wrong with CRISPR Babies
    • Roundtable 2 Recent Developments and Factors Affecting Stem Cell Research
    • Roundtable 3 Privacy, Ethic Society Legal Issues on Hematopoietic and Embryonic Stem Cells and Bio-Banking
    • Roundtable 4 Responsible Innovation and Trials with Autologous Stem Cells
    • Roundtable 5 Best Practice on RMSC Translational Medicine Young Talent Poster Sessions

    • Welcome, Award Ceremony, Banquet and Art Performance
    • Luncheon Showcase
    • Industrial Sponsored Cocktail Party
    • Lecture Tours to Campus
    • Field Trip to Industrial Parks
    • Local Impression Tech-Tour
    • Closing and Signing Ceremony
    Scientific and Technological Visits at Dalian Academy of Stem Cell Precision Medicine Innovation on
    November 2.


Early Bird Register

International Chair

Dr. Jürgen Hescheler,
Chairman, The German Society for Stem Cell Research, Germany

Co-Chair

Dr. Jing Liu,
Dean,Dalian Academy of Stem Cell Precision Medicine Innovation, China

News Updates

● The scientific program has updated
● Call for Session Chairs and Speakers
● Call for speakers, exhibitors and sponsors worldwide.
● Call for paper

Hosting Organizations

http://www.dlkx.gov.cn/templets/xiehui/images/logo.png
China Medicinal Biotech Association
IRCIT, Ministry of Science and Technology, China

Co-Hosting Organizations

Liaoning Province Stem Cell and Regenerative Medicine Industry Alliance

Liaoning Society for Cell Biology

Dalian Association for Science & Technology

Dalian Society of Stem Cell and Tissue Engineering

Dalian Innovation Institute of Stem Cell and Precision Medicine

The German Society for Stem Cell Research

Korea Council for Advanced Regenerative Medicine

Stem Cell Society of India

The American Society for Neural Therapy and Repair Federation of Bombay Blood Banks

Operation Organization


BIT Group Global Ltd.

Journal Partnerships

http://www.nrronline.org/images/NRRiPadAppadv.png
Neural Regeneration Research (NRR)

http://www.bitcongress.com/rmsc2019/right_clip_image001_0000.jpg
Journal of Stem cells and Regenerative Medicine

Download
Official Travel Agency

BIT World Travel Service, Inc.
Media Partners

Upcoming Events

Contact Us
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609-842, Fax: 0086-411-84796897
Copyright © 2007-2019 BIT Congress Inc.